NASDAQ:RCKT - Rocket Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$17.47 -1.54 (-8.10 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$17.47
Today's Range$17.40 - $19.00
52-Week Range$10.75 - $25.96
Volume385,086 shs
Average Volume367,918 shs
Market Capitalization$757.85 million
P/E Ratio-9.24
Dividend YieldN/A

Analyst Ratings

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Rocket Pharmaceuticals in the last 12 months. Their average twelve-month price target is $31.40, suggesting that the stock has a possible upside of 79.74%. The high price target for RCKT is $39.00 and the low price target for RCKT is $22.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $31.40$32.50$26.3333$28.50
Price Target Upside: 79.74% upside112.98% upside61.06% upside18.95% upside

Rocket Pharmaceuticals (NASDAQ:RCKT) Consensus Price Target History

Price Target History for Rocket Pharmaceuticals (NASDAQ:RCKT)

Rocket Pharmaceuticals (NASDAQ:RCKT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/19/2019OppenheimerSet Price TargetBuy$39.00HighView Rating Details
3/15/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$27.00HighView Rating Details
2/26/2019CowenInitiated CoverageOutperformLowView Rating Details
2/5/2019CIBCInitiated CoverageOutperform ➝ Outperform$39.00MediumView Rating Details
11/27/2018Leerink SwannInitiated CoverageOutperform$22.00HighView Rating Details
11/27/2018William BlairReiterated RatingBuyHighView Rating Details
9/13/2018LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$30.00HighView Rating Details
1/30/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$27.00HighView Rating Details
7/12/2017Canaccord GenuityDowngradeBuy ➝ HoldMediumView Rating Details
7/11/2017HC WainwrightDowngradeBuy ➝ Neutral$2.00HighView Rating Details
(Data available from 3/23/2017 forward)
This page was last updated on 3/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel